Search results for "Blood"

showing 10 items of 5199 documents

Circulating miR-200–family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time

2015

Objective To determine whether circulating micro-RNA (miR) 200a, miR-200b, and miR-141 have altered levels in patients with endometriosis compared with control individuals. Design Experimental laboratory study. Setting University. Patient(s) Patients with endometriosis (n = 61), laparoscopically confirmed endometriosis-free women (n = 35), and self-reported healthy women (n = 30) were included in the study. Intervention(s) None. Main Outcome Measure(s) Plasma miRNA levels in endometriosis patients and control subjects. Result(s) We found that the levels of studied miRNAs varied with blood collection time, being lower in the morning than in the evening. When blood collection time was taken i…

Adultmedicine.medical_specialtyTime FactorsEveningEndometriosisEndometriosisDiseaseReal-Time Polymerase Chain ReactionGastroenterologyYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansStage (cooking)030304 developmental biologyMorningGynecologyBlood Specimen Collection0303 health sciences030219 obstetrics & reproductive medicinebusiness.industryGene Expression ProfilingObstetrics and GynecologyMiddle Agedmedicine.disease3. Good healthMicroRNAsGene Expression RegulationReproductive MedicineCase-Control StudiesMultigene FamilyBiomarker (medicine)FemaleSample collectionbusinessBiomarkersBlood samplingFertility and Sterility
researchProduct

Endovascular Embolization of a Large High-Flow Splenic Arteriovenous Fistula and Aneurysm Using the Amplatzer Vascular Plug II.

2015

We describe the use of an Amplatzer Vascular Plug (AVP) II for embolizing a large high-flow splenic arteriovenous fistula and an aneurysm in a young patient. This patient presented to our center with persistent mild abdominal discomfort, 5 years after open splenectomy. Contrast-enhanced computed tomography angiography showed the presence of a fistula between the splenic arterial and splenic venous remnants and a resultant fusiform aneurysmal dilatation of the residual splenic vein. We decide to embolize the splenic artery with a 12-mm diameter AVP II with an oversizing by 70% of the vessel diameter. Celiac angiography performed 5 min postembolization revealed complete obliteration of the sp…

Adultmedicine.medical_specialtyTime FactorsFistulamedicine.medical_treatmentSplenectomyArteriovenous fistula030204 cardiovascular system & hematologySplenic arteryRadiation Dosage030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineAneurysmmedicine.arterymedicineHumansEmbolizationComputed tomography angiographymedicine.diagnostic_testbusiness.industryAngiography Digital SubtractionGeneral MedicineRadiation Exposuremedicine.diseaseAneurysmEmbolization TherapeuticSurgeryTreatment OutcomeSplenic veinRegional Blood FlowSplenic VeinArteriovenous FistulaSplenectomySurgeryFemaleRadiologyCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedSplenic ArteryBlood Flow VelocityAnnals of vascular surgery
researchProduct

A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladder

2012

Abstract Background β-Adrenoceptor agonists are effective in animal models of bladder dysfunction, and the human bladder primarily expresses the β3 receptor subtype. Objective To evaluate the efficacy and tolerability of the highly selective and potent β3-adrenoceptor agonist solabegron in a clinical proof-of-concept study in incontinent women with overactive bladder (OAB). Design, setting, and participants This was a randomized, double-blind trial in adult women with OAB (one or more 24-h incontinence episodes and eight or more average 24-h micturitions). Interventions Solabegron 50mg ( n =88), solabegron 125mg ( n =85), or placebo ( n =85)—all twice daily—were administered. Outcome measur…

Adultmedicine.medical_specialtyTime FactorsUrologymedia_common.quotation_subjectUrinary BladderArgentinaTaiwanPlacebo-controlled studyUrologyUrinationAdrenergic beta-3 Receptor AgonistsPlaceboBenzoatesUrinationDrug Administration ScheduleSouth AfricaYoung AdultSolabegronDouble-Blind MethodRepublic of KoreamedicineHumansAgedmedia_commonAniline CompoundsUrinary Bladder Overactivebusiness.industryBiphenyl CompoundsAustraliaMiddle Agedmedicine.diseaseEuropeUrodynamicsTreatment OutcomeUrinary IncontinenceBlood pressureOveractive bladderTolerabilityAmbulatoryLinear ModelsFemalebusinessNew Zealandmedicine.drugEuropean urology
researchProduct

Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration

2000

No abstract

Adultmedicine.medical_specialtyUltrasonography Doppler Transcranialmedicine.medical_treatmentSkull NeoplasmsElectrolytesIntraoperative PeriodCerebrospinal fluidPharmacokineticsInternal medicinemedicineHumansPulseRecombinant erythropoietinErythropoietinTransplantationChemotherapybusiness.industrySettore MED/27 - NeurochirurgiaErythropoietin transcranial dopplerRecombinant ProteinsEndocrinologyCytokineBlood-Brain BarrierNephrologyErythropoietinCerebrovascular CirculationInjections IntravenousIntravenous recombinant erythropoietin; cerebrospinal fluid; erythropoietin concentration.Femalebusinessmedicine.drug
researchProduct

Vena cava resection and bypass for recurrent cervical cancer

2021

A 42-year-old woman was diagnosed with a second para-aortic cervical cancer. The patient had undergone a radical hysterectomy with pelvic lymphadenectomy for FIGO stage IB1 squamous cervical cancer 3 years prior to current presentation. No adjuvant treatment was performed after the primary surgery

Adultmedicine.medical_specialtyVena cavacervical cancerretroperitoneal neoplasms Uterine Cervical NeoplasmUterine Cervical NeoplasmsRecurrent cervical cancerVena Cava InferiorResectionblood vesselgynecologic surgical proceduremedicineHumansStage (cooking)Radical HysterectomyCervical cancerbusiness.industryObstetrics and Gynecologyneoplasm recurrencemedicine.diseaseRetroperitoneal NeoplasmSurgeryOncologyFemaleNeoplasm Recurrence LocalPresentation (obstetrics)businessInternational Journal of Gynecologic Cancer
researchProduct

Neuromuscular and hormonal responses in elite athletes to two successive strength training sessions in one day

1988

Acute neuromuscular and endocrine adaptations to weight-lifting were investigated during two successive high intensity training sessions in the same day. Both the morning (I) (from 9.00 to 11.00 hours) and the afternoon (II) (from 15.00 hours to 17.00 hours) training sessions resulted in decreases in maximal isometric strength (p less than 0.01 and less than 0.05), shifts (worsening) in the force-time curve in the absolute scale (p less than 0.05 and ns.) and in decreases in the maximal integrated EMG (p less than 0.01 and less than 0.05) of the selected leg extensor muscles. Increases in serum total (p less than 0.05) and free testosterone (p less than 0.01) and in cortisol (p less than 0.…

Adultmedicine.medical_specialtyWeight LiftingPhysiologyStrength trainingPhysical ExertionIsometric exerciseElectromyographySex hormone-binding globulinIsometric ContractionSex Hormone-Binding GlobulinPhysiology (medical)Internal medicinemedicineHumansTestosteroneOrthopedics and Sports MedicineTestosteroneHydrocortisoneMorningLegPhysical Education and Trainingbiologymedicine.diagnostic_testElectromyographybusiness.industryMusclesPublic Health Environmental and Occupational HealthBlood ProteinsGeneral MedicineLuteinizing HormoneHormonesEndocrinologyGrowth HormoneLactatesbiology.proteinbusinessLuteinizing hormoneMuscle ContractionSportsmedicine.drugEuropean Journal of Applied Physiology and Occupational Physiology
researchProduct

Microalbuminuria fractional clearance and early renal permselectivity changes in essential hypertension.

1992

In order to verify if, in essential hypertension (EH), the microalbuminuria (AER) increase could be due to hemodynamic modifications or to glomerular structural changes, in 15 essential hypertensives (EHs) with 24-hour AER16 micrograms/min and in 15 EHs with 24-hour AERor = 16 micrograms/min, the day- and nighttime behavior of creatinine clearance (Ccr), as well as AER clearance (AER-C) and fractional clearance (AER-FC), and behavior of blood pressure (BP) was evaluated. Patients with 24-hour AER16 micrograms/min showed significantly higher values of 24-hour and daytime Ccr than the other group of EHs, while during the night period, there were no significant differences between the two grou…

Adultmedicine.medical_specialtyanimal structuresCell Membrane Permeabilityendocrine system diseasesRenal functionHemodynamicsurologic and male genital diseasesEssential hypertensionKidneyNephropathyInternal medicinemedicineAlbuminuriaHumansLeast-Squares AnalysisProteinuriabusiness.industryAlbuminmedicine.diseasefemale genital diseases and pregnancy complicationsBlood Pressure MonitorsCircadian RhythmBlood pressureEndocrinologyNephrologyHypertensionMicroalbuminuriamedicine.symptombusinesshuman activitiesGlomerular Filtration RateAmerican journal of nephrology
researchProduct

VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY

2008

Summary.  Background: Combined vitamin K-dependent clotting factor (VKCF) deficiency type 2 (VKCFD2) is a rare bleeding disorder caused by mutated vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1) gene. Methods and results: An Italian patient with moderate to severe bleeding tendency was genotyped, and found to be homozygous for the unique VKORC1 mutation (Arg98Trp) so far detected in VKCFD2. The activity levels of VKCFs were differentially reduced, and inversely related to the previously estimated affinity of procoagulant factor propeptides for the γ-carboxylase. The normal (factor IX) or reduced antigen levels (other VKCFs) produced a gradient in specific activities. Vitamin K su…

Adultmedicine.medical_specialtycoagulation factor levelsVitamin KProtein SMixed Function OxygenasesTissue factorchemistry.chemical_compoundInternal medicineVitamin K Epoxide ReductasesmedicineVKCFD2HumansFactor IXClotting factorCoagulation factor levels; Thrombin generation; Vitamin K supplementation; VKCFD2; VKORC1 mutation;biologyFactor VIIChemistryFactor XHomozygotevitamin K supplementationHematologyBlood Coagulation DisordersEndocrinologyTreatment OutcomeCoagulationthrombin generationImmunologyMutationbiology.proteinFemaleBlood Coagulation TestsVKCFD2 VKORC1 mutation coagulation factor levels thrombin generation vitamin K supplementationProtein Cmedicine.drugHalf-LifeVKORC1 mutation
researchProduct

Physical inactivity from youth to adulthood and adult cardiometabolic risk profile

2020

Adults with a low physical activity (PA) level are at increased risk for cardiometabolic diseases, but little is known on the association between physical inactivity since youth and cardiometabolic health in adulthood. We investigated the association of persistent physical inactivity from youth to adulthood with adult cardiometabolic risk factors. Data were drawn from the ongoing Cardiovascular Risk in Young Finns Study with seven follow-ups between 1980 and 2011 (baseline age 3–18 years, n = 1961). Physical activity data from a standardized questionnaire was expressed as a PA-index. Using the PA-index, four groups were formed: 1)persistently physically inactive (n = 246), 2)decreasingly ac…

Adultmedicine.medical_specialtyelintavatWaistAdolescentlongitudinalEpidemiologymedicine.medical_treatmentinactive lifestylepitkittäistutkimusLower risk01 natural sciencesBody Mass Index03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk FactorsInternal medicinemedicineHumans030212 general & internal medicine0101 mathematicsChildExerciseFinland2. Zero hungerTriglyceridebusiness.industryInsulincardiovascular010102 general mathematicsPublic Health Environmental and Occupational Healthlapsuusmedicine.diseasechildhood [CVD]ObesityBlood pressurechemistryCardiovascular DiseasesChild Preschoolsydän- ja verisuonitauditnuoruusMetabolic syndromeSedentary BehaviorWaist CircumferencebusinessBody mass indexterveysriskitfyysinen aktiivisuus
researchProduct

Uterine effects of metformin administration in anovulatory women with polycystic ovary sindrome

2006

Background Metformin has been shown to improve fertility in anovulatory patients with polycystic ovary syndrome (PCOS), inducing not only a high ovulation and pregnancy rate but also reducing the incidence of miscarriages. The aim of the present study was to evaluate the uterine effects of metformin in patients with PCOS who ovulated under metformin. Methods Thirty-seven non-obese primary infertile anovulatory patients with PCOS and another 30 age- and body mass index-matched healthy women (control group) were studied. PCOS patients were treated with metformin (850 mg twice daily) for 6 months, whereas the control group did not receive any treatment. In these PCOS patients who ovulated whil…

Adultmedicine.medical_specialtyendocrine system diseasesPhysiologymedia_common.quotation_subjectUterusEndometriumFertility AgentsAnovulationEndometriumanovulation; endometrium; metforminMenstruation-Inducing AgentUltrasoundmedicinePCOSHumansOvulationFertility Agentmedia_commonGynecologyMenstruation-Inducing Agentsbusiness.industryRehabilitationUterusanovulation endometrium metformin PCOS ultrasoundnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsMetforminMetforminPregnancy ratemedicine.anatomical_structureUteruReproductive MedicineIn uteroRegional Blood FlowFemalebusinessmedicine.drugAnovulationHumanPolycystic Ovary SyndromeDevelopmental Biology
researchProduct